Alzheimer's disease & dementia

Promising Alzheimer's 'drug' halts memory loss

A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer's disease, according to Northwestern Medicine research.

Diseases, Conditions, Syndromes

Measles: New efforts needed to stop an old disease

New diseases grab headlines. The latest influenza scare – H7N9 – has prompted much speculation about the direction the virus might take. And rightly so, as vaccines to fight new viruses can take some time to be produced. ...

Neuroscience

Research sheds new light on traumatic brain injuries

Even a mild injury to the brain can have long lasting consequences, including increased risk of cognitive impairment later in life. While it is not yet known how brain injury increases risk for dementia, there are indications ...

Alzheimer's disease & dementia

Forget about plaque when diagnosing Alzheimer's Disease

(Medical Xpress)—An Australian study has shown that plaque, long considered to be the hallmark of Alzheimer's disease, is one of the last events to occur in the Alzheimer's brain. This finding will impact the current debate ...

Oncology & Cancer

Brain tumour cells killed by anti-nausea drug

(Medical Xpress)—New research from the University of Adelaide has shown for the first time that the growth of brain tumours can be halted by a drug currently being used to help patients recover from the side effects of ...

Other

Elan moves to deter takeover bid

(AP)—Irish drug maker Elan Corp. announced Monday it will pay shareholders a recurring special dividend linked to the sales of the multiple sclerosis treatment Tysabri.

Medical research

p38beta MAPK not critical to brain inflammation, study finds

(Medical Xpress)—A study by a leading Alzheimer's researcher at the University of Kentucky provides new evidence that will help researchers home in on the molecular mechanisms involved in inflammation of the central nervous ...

page 10 from 12